COVID-19, Infectious Diseases Clinical Trial 20213009

[LCID Study Number: 20213009]

COVID-19 Post-hospital Thrombosis Prevention Trial: An Adaptive, Multicenter, Prospective, Randomized Platform Trial Evaluating the Efficacy and Safety of Antithrombotic Strategies in Patients With COVID-19 Following Hospital Discharge

The purpose of this study is to compare the effectiveness and safety of antithrombotic therapy with no antithrombotic therapy after hospitalization for 48 hours or longer for COVID-19.

Disease/Condition: COVID-19, Infectious Diseases

Department: Pulmonary and Critical Care

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-2734

View NCT ID 04650087 on ClinicalTrials.gov
Protocol #: 20213009
Principal Investigator(s): Julie M. Freiman
Study Coordinator(s): Deborah Gannon
Trial Phase: Sponsor Initiated Study Phase 3